SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvoke Plc Regulatory News (EVOK)

Share Price Information for Evoke Plc (EVOK)

Share Price is delayed by 15 minutes
Get Live Data
46.20    0.00 (0.00%)
Bid:
0.00
Ask:
47.30
Spread: 1.00 (2.16%)
Market Cap: £207.96m
EVOK Live PriceLast checked at - London Stock Exchange

Intraday Evoke Plc Share Chart

Statement regarding media speculation

20 Apr 2026 07:01

RNS Number : 0950B
Evoke PLC
20 April 2026
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

20 April 2026

evoke plc

("evoke" or the "Company")

Statement regarding media speculation

evoke notes the recent media speculation and confirms that it is in discussions with Bally's Intralot S.A. ("Bally's Intralot") regarding a possible offer for the entire issued and to be issued share capital of the Company at a price of 50 pence per share (the "Proposal"). The Proposal is expected to comprise an all-share combination with a partial cash alternative.

There can be no certainty that an offer will be made or as to the terms on which any offer might be made.

The Board of evoke is evaluating the possible offer together with its financial advisers, Morgan Stanley and Rothschild & Co.

evoke shareholders are advised not to take any action in relation to the Proposal.

A further announcement will be made when appropriate.

Bally's Intralot has confirmed to the Company that it will, by no later than 5.00 p.m. (London time) on 18 May 2026, being 28 days after the date of this announcement, either announce a firm intention to make an offer for the Company or announce that it does not intend to make an offer. This deadline can be extended with the consent of the Company. 

Bally's Intralot has confirmed that any firm offer, if made, would be subject to customary conditions and approvals and that it reserves the right to vary the terms of any such offer, including the price, the form and mix of consideration and the structure of the transaction.

This announcement has been made with the consent of the Bally's Intralot Board.

The person responsible for arranging the release of this announcement on behalf of the Company is Fredrik Ekdahl.

 

For further information, please contact:

evoke

Per Widerström, CEO

Sean Wilkins, CFO

James Finney, Director of IR

Tel: +44 (0) 800 029 3050

Media - Hudson Sandler

Alex Brennan / Hattie Dreyfus / Andy Richards

Tel: +44 (0) 20 7796 4133

Morgan Stanley

Laurence Hopkins

Ben Grindley

Paolo Della Rovere

Tel: +44 (0) 20 7425 8000

Rothschild & Co.

Daniel Ross

Edward Duckett

Ashley Gillard

Tel: +44 (0) 20 7280 5000

The City Code on Takeovers and Mergers

The City Code on Takeovers and Mergers (the "Code") does not apply to the Company as it is registered in Gibraltar. As a result, a takeover offer for the Company will not be regulated by the UK Panel on Takeovers and Mergers (the "Panel"). The Company's articles of association contain certain provisions requiring the Company to use its reasonable endeavours to apply the rules of the Code to a takeover offer for the Company (except where not in the best interest of the Company to do so), although these do not provide the full protections afforded by the Code and the enforcement of such provisions is the responsibility of the Company, not the Panel. Accordingly, shareholders of the Company are reminded that the Panel does not have responsibility, in relation to the Company, for ensuring compliance with the Code and is not able to answer shareholders' questions in that regard.

Publication on website

A copy of this announcement will be available at www.evokeplc.com, by no later than 12 noon (London time) on 21 April 2026. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Number of shares in issue

As at the close of business on 17 April 2026 (being the business day prior to the date of this announcement), evoke confirms that it had in issue 450,634,446 ordinary shares of GBP £0.005 each (excluding shares held in treasury) with voting rights and admitted to trading on the main market of the London Stock Exchange under the ISIN code GI000A0F6407.

Further information

This announcement is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this announcement in whole or in part, directly or indirectly, in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

Morgan Stanley & Co. International plc ("Morgan Stanley"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is acting exclusively for evoke and for no one else in connection with the possible offer and neither Morgan Stanley nor any of its affiliates, nor their respective directors, officers, employees or agents will be responsible to anyone other than evoke for providing the protections afforded to its clients or for providing advice in relation to the possible offer, the contents of this announcement or any other matters referred to in this announcement.

N.M. Rothschild & Sons Limited ("Rothschild & Co"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for evoke and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than evoke for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCKZGZDKGRGVZG
Date   Source Headline
25th Apr 20257:00 amRNSQ1 2025 trading update
22nd Apr 20257:43 amRNSNotice of Q1 2025 trading update
22nd Apr 20257:00 amRNSHolding(s) in Company
14th Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Apr 20258:16 amRNSHolding(s) in Company
2nd Apr 20258:15 amRNSHolding(s) in Company
2nd Apr 20257:00 amRNSPublication of Annual Report
1st Apr 20259:08 amRNSNotification of Transactions by PDMR
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20259:28 amRNSAwards Granted under the Long Term Incentive Plan
26th Mar 20257:00 amRNSFY2024 Results
25th Mar 20259:13 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSTotal Voting Rights
17th Feb 20257:00 amRNSNotice of Results
3rd Feb 20258:15 amRNSTotal Voting Rights
29th Jan 20257:00 amRNSNotification of Transactions by PDMR
17th Jan 20257:05 amRNSevoke Announcement Containing Company Information
17th Jan 20257:00 amRNS2024 Post-close Trading Update
13th Jan 20254:30 pmRNSNotice of Trading Update
10th Jan 20253:34 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
11th Nov 202410:23 amRNSHolding(s) in Company
1st Nov 20249:23 amRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
29th Oct 202411:41 amRNSHolding(s) in Company
23rd Oct 20247:00 amRNSBlock Listing Six Monthly Return
18th Oct 20247:05 amRNSevoke Announcement Containing Company Information
18th Oct 20247:00 amRNSQ3 2024 trading update
11th Oct 20249:30 amRNSNotice of Q3 2024 trading update
1st Oct 20247:00 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAppointment of a Non-Executive Director
10th Sep 20248:43 amRNSDirector Declaration
2nd Sep 20247:00 amRNSTotal Voting Rights
23rd Aug 20247:00 amRNSAcquisition of Winner.ro
21st Aug 20248:52 amRNSNotification of Transactions by PDMR
19th Aug 20245:01 pmRNSNotification of Transactions by PDMR
16th Aug 20247:00 amRNSNotification of Transactions by PDMR
16th Aug 20247:00 amRNSNotification of Transactions by PDMR
15th Aug 20243:10 pmRNSNotification of Transactions by PDMR
15th Aug 20247:05 amRNSevoke Announcement Containing Company Information
15th Aug 20247:00 amRNSH1 2024 Interim Results
2nd Aug 20249:21 amRNSNotice of Interim Results
1st Aug 20247:00 amRNSTotal Voting Rights
18th Jul 20247:05 amRNSevoke Announcement Containing Company Information
18th Jul 20247:00 amRNSH1 2024 Trading Update
1st Jul 20249:40 amRNSWilliam Hill Limited - Annual Financial Report
1st Jul 20247:00 amRNSTotal Voting Rights
17th Jun 202410:25 amRNSAppointment of Corporate Broker
3rd Jun 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.